Long-term consequences of estrogen and estrogen-progestin replacement
暂无分享,去创建一个
[1] H. Iwase,et al. [Breast cancer]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[2] R. Bergström,et al. Women with climacteric symptoms: A target group for prevention of rapid bone loss and osteoporosis , 1992, Osteoporosis International.
[3] H. Adami,et al. Cohort study of oestrogen treatment and the risk of endometrial cancer: Evaluation of method and its applicability , 1983, European Journal of Clinical Pharmacology.
[4] H. Adami,et al. Cause‐Specific Mortality in Women Receiving Hormone Replacement Therapy , 1997, Epidemiology.
[5] E. Eaker,et al. The risk of acute myocardial infarction after oestrogen and oestrogen‐progestogen replacement , 1992, British journal of obstetrics and gynaecology.
[6] S. Thacker,et al. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. , 1991, JAMA.
[7] S. Thacker,et al. A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer , 1991 .
[8] G. Colditz,et al. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆ , 1991 .
[9] R. Hoover,et al. Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort. , 1991, Journal of clinical epidemiology.
[10] W. Willett,et al. Prospective study of estrogen replacement therapy and risk of breast cancer in postmenopausal women. , 1990, JAMA.
[11] H. Adami,et al. Hormone replacement therapy and the risk for first hip fracture. A prospective, population-based cohort study. , 1990, Annals of internal medicine.
[12] R. Hoover,et al. The Risk of Breast Cancer after Estrogen and Estrogen-Progestin Replacement , 1990 .
[13] Persson Ingemar,et al. Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort. , 1990 .
[14] R. Hoover,et al. Risk of cancer in women receiving hormone replacement therapy , 1989, International journal of cancer.
[15] R. Hoover,et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. , 1989, The New England journal of medicine.
[16] H. Adami,et al. PROGNOSIS AFTER BREAST CANCER DIAGNOSIS IN WOMEN EXPOSED TO ESTROGEN AND ESTROGEN-PROGESTOGEN REPLACEMENT THERAPY , 1989 .
[17] R. Hoover,et al. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study. , 1989, BMJ.
[18] M. Pike,et al. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer. , 1988, European journal of cancer & clinical oncology.
[19] K. McPherson,et al. Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy , 1988, British journal of obstetrics and gynaecology.
[20] S. Sidney,et al. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. , 1987, Obstetrics and gynecology.
[21] M. Coleman,et al. Long‐term surveillance of mortality and cancer incidence in women receiving hormone replacemen therapy , 1987 .
[22] I Persson,et al. The relation between survival and age at diagnosis in breast cancer. , 1986, The New England journal of medicine.
[23] H. Adami,et al. Climacteric Symptoms and Estrogen Replacement Therapy In Women with Endometrial Carcinoma , 1986, Acta obstetricia et gynecologica Scandinavica.